160 related articles for article (PubMed ID: 20363601)
1. In vitro permeation of diclofenac salts from lyotropic liquid crystalline systems.
Yariv D; Efrat R; Libster D; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2010 Jul; 78(2):185-92. PubMed ID: 20363601
[TBL] [Abstract][Full Text] [Related]
2. On structural transitions in a discontinuous micellar cubic phase loaded with sodium diclofenac.
Efrat R; Aserin A; Garti N
J Colloid Interface Sci; 2008 May; 321(1):166-76. PubMed ID: 18279886
[TBL] [Abstract][Full Text] [Related]
3. Penetratin-induced transdermal delivery from H(II) mesophases of sodium diclofenac.
Cohen-Avrahami M; Libster D; Aserin A; Garti N
J Control Release; 2012 May; 159(3):419-28. PubMed ID: 22306174
[TBL] [Abstract][Full Text] [Related]
4. HIV-TAT enhances the transdermal delivery of NSAID drugs from liquid crystalline mesophases.
Cohen-Avrahami M; Shames AI; Ottaviani MF; Aserin A; Garti N
J Phys Chem B; 2014 Jun; 118(23):6277-87. PubMed ID: 24798650
[TBL] [Abstract][Full Text] [Related]
5. H(II) mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac.
Cohen-Avrahami M; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2010 Jun; 77(2):131-8. PubMed ID: 20189781
[TBL] [Abstract][Full Text] [Related]
6. Sodium diclofenac and cell-penetrating peptides embedded in H(II) mesophases: physical characterization and delivery.
Cohen-Avrahami M; Libster D; Aserin A; Garti N
J Phys Chem B; 2011 Sep; 115(34):10189-97. PubMed ID: 21749044
[TBL] [Abstract][Full Text] [Related]
7. Reversed hexagonal lyotropic liquid-crystal and open-shell glycodendrimers as potential vehicles for sustained release of sodium diclofenac.
Bitan-Cherbakovsky L; Libster D; Appelhans D; Voit B; Aserin A; Garti N
J Phys Chem B; 2014 Apr; 118(14):4016-24. PubMed ID: 24617448
[TBL] [Abstract][Full Text] [Related]
8. Effect of sodium diclofenac loads on mesophase components and structure.
Efrat R; Shalev DE; Hoffman RE; Aserin A; Garti N
Langmuir; 2008 Jul; 24(14):7590-5. PubMed ID: 18547072
[TBL] [Abstract][Full Text] [Related]
9. Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications.
Libster D; Aserin A; Garti N
J Colloid Interface Sci; 2011 Apr; 356(2):375-86. PubMed ID: 21315366
[TBL] [Abstract][Full Text] [Related]
10. Spray dried glyceryl monooleate-magnesium trisilicate dry powder as cubic phase precursor.
Shah MH; Biradar SV; Paradkar AR
Int J Pharm; 2006 Oct; 323(1-2):18-26. PubMed ID: 16846704
[TBL] [Abstract][Full Text] [Related]
11. On the correlation between the structure of lyotropic carriers and the delivery profiles of two common NSAIDs.
Cohen-Avrahami M; Shames AI; Ottaviani MF; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2014 Oct; 122():231-240. PubMed ID: 25048360
[TBL] [Abstract][Full Text] [Related]
12. Complex dendrimer-lyotropic liquid crystalline systems: structural behavior and interactions.
Bitan-Cherbakovsky L; Libster D; Aserin A; Garti N
J Phys Chem B; 2011 Oct; 115(42):11984-92. PubMed ID: 21902258
[TBL] [Abstract][Full Text] [Related]
13. Phospholipids-embedded fully dilutable liquid nanostructures. Part 2: The role of sodium diclofenac.
Amsalem O; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):422-9. PubMed ID: 20708909
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization of lyotropic liquid crystals containing a dendrimer for solubilization and release of gallic acid.
Bitan-Cherbakovsky L; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2013 Dec; 112():87-95. PubMed ID: 23973908
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylcholine embedded micellar systems: enhanced permeability through rat skin.
Spernath A; Aserin A; Sintov AC; Garti N
J Colloid Interface Sci; 2008 Feb; 318(2):421-9. PubMed ID: 18005978
[TBL] [Abstract][Full Text] [Related]
16. Interaction between lamellar (vesicles) and nonlamellar lipid liquid-crystalline nanoparticles as studied by time-resolved small-angle X-ray diffraction.
Vandoolaeghe P; Barauskas J; Johnsson M; Tiberg F; Nylander T
Langmuir; 2009 Apr; 25(7):3999-4008. PubMed ID: 19714888
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the link between self-assembled mesophase structure and drug release.
Phan S; Fong WK; Kirby N; Hanley T; Boyd BJ
Int J Pharm; 2011 Dec; 421(1):176-82. PubMed ID: 21963475
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous micellar solubilization within lyotropic liquid crystals interfaces.
Goldmünz EY; Aserin A; Ottaviani MF; Shames AI; Garti N
J Colloid Interface Sci; 2024 May; 672():552-563. PubMed ID: 38852356
[TBL] [Abstract][Full Text] [Related]
19. The effect of dendrimer generations on the structure of Q(G) LLC mesophase and drug release.
Bitan-Cherbakovsky L; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2014 Oct; 122():30-37. PubMed ID: 25016542
[TBL] [Abstract][Full Text] [Related]
20. Liquid crystalline systems for transdermal delivery of celecoxib: in vitro drug release and skin permeation studies.
Estracanholli EA; Praça FS; Cintra AB; Pierre MB; Lara MG
AAPS PharmSciTech; 2014 Dec; 15(6):1468-75. PubMed ID: 24980082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
